Skip to content

Clinical trials

Thalassemia trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thalassemia Country / region: Italy Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20052
20071
20081
20091
20121
20143
20151
20161
20171
20183
20191
20211
20225
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting4
Terminated3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals10
Vertex Pharmaceuticals Incorporated4
Bellicum Pharmaceuticals2
Ente Ospedaliero Ospedali Galliera2
ApoPharma1
Celgene1
Cyprus Institute of Neurology and Genetics1
Federico II University1
Fondazione per la Ricerca sulle Anemie ed Emoglobinopatie in Italia1
Forma Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thalassemia27
beta-Thalassemia12
Hemoglobinopathies9
Anemia, Sickle Cell8
Anemia6
Anemia, Diamond-Blackfan6
Myelodysplastic Syndromes6
Genetic Diseases, Inborn5
Hematologic Diseases5
Iron Overload5

Trials

Showing 51 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.